Kala Pharmaceuticals Inc. (KALA)
NASDAQ: KALA
· Real-Time Price · USD
8.04
0.17 (2.16%)
At close: Aug 14, 2025, 3:59 PM
7.90
-1.80%
Pre-market: Aug 15, 2025, 08:44 AM EDT
Kala Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 254K | 254K | 254K | 70K | 70K | 70K | 70K | 1.23M | 1.65M | 3.75M | 5.12M | 5.75M | 8.39M | 9.35M | 11.24M | 11.62M | 10.78M | 8.56M |
Cost of Revenue | 199K | 193K | 259K | 260K | 354K | 370K | 304K | 2.79M | 2.65M | 4.34M | 5.12M | 3.98M | 4.88M | 4.12M | 4.1M | 4.04M | 3.83M | 3.57M |
Gross Profit | -71K | -65K | -63K | -260K | -354K | -370K | -304K | -1.57M | -1M | -597K | n/a | 1.77M | 3.52M | 5.23M | 7.14M | 7.58M | 6.94M | 4.98M |
Operating Income | -41.14M | -39.72M | -40.98M | -40.63M | -39.17M | -39.17M | -38.92M | -40.06M | -46.1M | -63.32M | -82.49M | -119.06M | -130.56M | -132.78M | -130.25M | -112.41M | -112.19M | -104.42M |
Interest Income | 1.92M | 2.02M | 2.06M | 2.19M | 2.33M | 2.54M | 2.71M | 2.46M | 1.98M | 1.33M | 664K | 322K | 104K | 69K | 104K | 134K | 169K | 238K |
Pretax Income | -37.23M | -35.65M | -38.51M | -38.96M | -38.72M | -39.55M | -42.2M | -46.41M | -8.64M | -26.34M | -44.82M | -79.55M | -136.75M | -145.13M | -142.6M | -126.15M | -125.97M | -112.78M |
Net Income | -37.23M | -35.65M | -38.51M | -38.96M | -38.72M | -39.55M | -42.2M | -47.43M | -9.65M | -26.5M | -45.05M | -78.76M | -135.96M | -145.2M | -142.6M | -126.15M | -125.97M | -112.78M |
Selling & General & Admin | 17.84M | 17.51M | 18.34M | 18.69M | 19.09M | 19.73M | 20.34M | 21.62M | 26.37M | 44.08M | 65.03M | 83.23M | 99.03M | 104.34M | 105.06M | 107.5M | 106.04M | 93.36M |
Research & Development | 22.64M | 21.67M | 21.96M | 21.49M | 21.88M | 20.9M | 18.59M | 17.19M | 17.03M | 17.22M | 17.65M | 16.74M | 14.23M | 12.86M | 11.52M | 12.5M | 13.09M | 16.04M |
Other Expenses | n/a | n/a | -66K | -66K | -66K | -66K | 1.62M | 248K | 248K | 307K | -1.31M | 59K | 59K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 40.48M | 39.18M | 40.24M | 40.12M | 40.9M | 40.57M | 40.54M | 40.43M | 45.02M | 62.92M | 82.69M | 99.97M | 113.27M | 117.2M | 116.58M | 120M | 119.13M | 109.4M |
Interest Expense | 2.86M | 3.24M | 5.78M | 5.86M | 5.84M | 5.79M | 5.81M | 5.92M | 5.91M | 6.71M | 7.27M | 7.76M | 8.39M | 8.27M | 8.38M | 8.47M | 8.56M | 8.6M |
Selling & Marketing Expenses | n/a | n/a | n/a | -70K | -70K | -70K | -70K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.14M | 39.75M | 40.85M | 40.74M | 41.25M | 40.86M | 40.77M | 40.58M | 45.03M | 64.71M | 85.25M | 103.95M | 118.14M | 121.32M | 120.67M | 124.04M | 122.96M | 112.98M |
Income Tax Expense | -22.72K | -22.72K | -22.72K | n/a | n/a | n/a | n/a | 1.02M | 1.02M | 169K | 232K | -785K | -769K | 79K | 59K | -137K | -102K | -224K |
Shares Outstanding (Basic) | 6.51M | 6.35M | 4.69M | 4.63M | 3.03M | 2.81M | 2.71M | 2.55M | 2.39M | 2.07M | 1.61M | 1.5M | 1.47M | 1.47M | 1.3M | 1.3M | 1.29M | 1.23M |
Shares Outstanding (Diluted) | 6.51M | 6.35M | 4.69M | 4.63M | 3.03M | 2.81M | 2.71M | 2.55M | 2.39M | 2.07M | 1.61M | 1.51M | 1.47M | 1.47M | 1.3M | 1.31M | 1.29M | 1.23M |
EPS (Basic) | -6.79 | -8.24 | -11.03 | -12.47 | -13.95 | -15.15 | -17.94 | -23.36 | -0.56 | -14.7 | -30.12 | -58.08 | -99.09 | -108.86 | -111.11 | -101.88 | -105.2 | -97.85 |
EPS (Diluted) | -6.79 | -8.24 | -11.03 | -12.47 | -13.95 | -15.15 | -17.94 | -23.36 | -0.7 | -14.84 | -30.26 | -58.22 | -98.88 | -108.65 | -110.9 | -101.67 | -105.2 | -97.85 |
EBITDA | -35.82M | -32.85M | -32.47M | -32.84M | -32.52M | -33.39M | -36M | -40.18M | -46.8M | -63.41M | -81.07M | -115.3M | -126.8M | -134.82M | -131.75M | -114.96M | -115.33M | -102.72M |
EBIT | -32.19M | -30.23M | -32.73M | -33.1M | -32.88M | -33.76M | -36.38M | -40.49M | -2.73M | -19.63M | -37.56M | -71.78M | -128.36M | -136.86M | -134.22M | -117.67M | -117.41M | -104.18M |
Depreciation & Amortization | 200K | 261K | 259K | 260K | 354K | 370K | 381K | 391K | 385K | 679K | 940K | 1.07M | 1.77M | 2.25M | 2.69M | 2.71M | 2.08M | 1.46M |